会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 15. 发明申请
    • NUCLEIC ACID MOLECULES AND POLYPEPTIDES FOR A HUMAN CATION CHANNEL POLYPEPTIDE
    • 人体通道多肽的核酸分子和多肽
    • WO02068471A3
    • 2003-05-01
    • PCT/US0150413
    • 2001-12-21
    • SQUIBB BRISTOL MYERS CO
    • FEDER JOHNMINTIER GABERAMANATHAN CHANDRAWESTPHAL RYAN
    • C07K14/705C12N15/12A01K67/027C07K16/28C12N15/62C12Q1/68G01N33/50G01N33/577
    • C07K14/705A01K2217/05C07K2319/00
    • The present invention relates to novel human nucleic acid molecules encoding novel human cation channels, and proteins and polypeptides encoded by such nucleic acid molecules. More specifically, the nucleic acid molecules of the invention include the novel human gene designated HBMYCNG. The proteins and polypeptides of the invention represent a novel cation channel that may be therapeutically valuable targets for drug delivery in the treatment of human diseases which involve calcium, sodium, potassium or other ionic homeostatic dysfunction, such as central nervous system (CNS) disorders, e.g., stroke, anxiety and depression, or degenerative neurological disorders such as Alzheimer's disease or Parkinson's disease, or other disorders such as cardiac disorders, e.g., arrhythmia, diabetes, chronic pain, hypercalcemia, hypocalcemia, hypercalciuria, hypocalciuria, or ion disorders associated with immunological disorders, gasto-intestinal (GI) tract disorders, or renal or liver disease.
    • 本发明涉及编码新型人类阳离子通道的新型人核酸分子,以及由该核酸分子编码的蛋白质和多肽。 更具体地,本发明的核酸分子包括命名为HBMYCNG的新型人基因。 本发明的蛋白质和多肽代表一种新的阳离子通道,其可能是用于药物递送的治疗有价值的靶标,其用于治疗人类疾病,所述疾病涉及钙,钠,钾或其它离子稳态功能障碍,例如中枢神经系统(CNS) 例如中风,焦虑和抑郁,或退行性神经障碍如阿尔茨海默病或帕金森病,或其他疾病如心脏病,例如心律失常,糖尿病,慢性疼痛,高钙血症,低钙血症,高钙尿症,低钙血症或与 免疫学障碍,胃肠(GI)道疾病或肾或肝脏疾病。